Molibresib
CAS number: 1260907-17-2
Molibresib is under investigation in clinical trial NCT01943851 (A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies).
Related images
Structures of selected published BET inhibitors and selected hydroxamic acid HDAC inhibitors.
Related Questions and Answers
No related questions yet